Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Panbela Therapeutics Inc (PBLA)

Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Panbela Provides Business Update and Reports Q3 2024 Financial Results GlobeNewswire - Thu Nov 14, 2024

PBLA : 0.0002 (-98.20%)
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024 GlobeNewswire - Thu Oct 31, 2024

PBLA : 0.0002 (-98.20%)
Panbela Announces First Patient Enrolled in its Aspire Trial Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma Globe Newswire - Thu Aug 11, 2022

Expects interim data by early 2024...

PBLA : 0.0002 (-98.20%)
Panbela Expands Aspire Trial to Australia, Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma Globe Newswire - Thu Aug 4, 2022

MINNEAPOLIS, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

PBLA : 0.0002 (-98.20%)
Panbela Schedules Conference Call on, August 15, 2022, to Report 2022 Second Quarter Financial Results Globe Newswire - Mon Aug 1, 2022

MINNEAPOLIS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

PBLA : 0.0002 (-98.20%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 ACCESS Newswire - Thu Jul 8, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled...

TRIQ : 0.4000 (-27.27%)
DMIFF : 0.0025 (unch)
PBLA : 0.0002 (-98.20%)
THBRF : 1.2101 (-3.19%)
ATGN : 0.4750 (-3.06%)
STRR : 11.04 (-2.60%)
ADXN : 6.45 (+4.03%)
MKTY : 12.66 (-1.40%)
BTX : 9.03 (+0.89%)
FLUX : 0.8456 (-7.28%)
NMTC : 3.24 (unch)
NEPH : 3.34 (+0.30%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 ACCESS Newswire - Wed Jun 23, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual...

DMIFF : 0.0025 (unch)
PBLA : 0.0002 (-98.20%)
ATGN : 0.4750 (-3.06%)
STRR : 11.04 (-2.60%)
ADXN : 6.45 (+4.03%)
MKTY : 12.66 (-1.40%)
FLUX : 0.8456 (-7.28%)
NMTC : 3.24 (unch)
NEPH : 3.34 (+0.30%)
ACER : 0.6601 (-17.95%)
BSFC : 0.0013 (+30.00%)
DTST : 3.13 (-8.21%)

Barchart Exclusives

Mark Cuban Says Everything in the Hospital Could Cost $1 And Insurance Companies Would Still Raise the Prices to ‘Crush People’s Financial Situation’ Barchart - 1 hour ago
Billionaire Mark Cuban argued that even if hospital services cost just $1, large insurance conglomerates would still drive prices higher, highlighting opportunities for healthcare disruptors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.